Rapid Micro Biosystems Inc - Class A

RPID | $0.9225 -1.86% 47K

(0.0% 1d) (-2.2% 1m) (-10.5% 1y) (0.0% 2d) (0.5% 3d) (-1.0% 7d) (-2.83% volume)
Earnings Calendar: 2024-03-01
Market Cap: $ 34,578,583
https://www.rapidmicrobio.com
Sec Filling | Patents | 2021 employees

Rapid Micro Biosystems is the industry leader in automated detection of microbial contamination with innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products. The company’s Growth Direct® platform - the only growth-based platform to fully automate traditional microbial testing - detects contamination more quickly, delivering compelling economic benefits to manufacturers while improving their quality control (QC) process. The company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, and global locations in Germany and the Netherlands.

add to watch list Paper trade email alert is off

Press-releases

Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
Published: 2024-03-19 (Crawled : 21:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -2.24% | O: 1.92% H: 0.0% C: -0.03%
rapid biosystems meeting

Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Published: 2024-03-12 (Crawled : 21:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -1.31% | O: 1.84% H: 3.09% C: 1.39%
life rapid biosystems sciences

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-06 (Crawled : 00:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -6.0% | O: 1.0% H: 0.0% C: -3.07%
nasdaq rapid biosystems grants

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Published: 2024-03-01 (Crawled : 12:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -14.55% | O: 4.55% H: 0.0% C: -14.78%
rapid year biosystems financial results

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
Published: 2024-02-27 (Crawled : 22:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -5.86% | O: -2.84% H: 3.08% C: 3.03%
rapid biosystems

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
Published: 2024-02-20 (Crawled : 22:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| 1.08% | O: 6.45% H: 0.0% C: -5.05%
rapid year biosystems financial results

Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
Published: 2024-01-10 (Crawled : 12:30) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -6.93% | O: -0.99% H: 1.24% C: -4.0%
direct rapid biosystems system application growth

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
Published: 2024-01-10 (Crawled : 12:30) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| -6.93% | O: -0.99% H: 1.24% C: -4.0%
rapid year biosystems revenue

Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
Published: 2024-01-04 (Crawled : 12:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| 4.44% | O: 16.67% H: 1.9% C: -6.27%
direct rapid control growth platform

Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 12:00) - globenewswire.com
RPID | $0.9225 -1.86% 47K

| 3.63% | O: 0.0% H: 0.0% C: -0.78%
conference rapid biosystems

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001380106-24-000088	4	2024-03-13	2024-03-11	Sell	F	9569	188738
0001380106-24-000086	4	2024-03-13	2024-03-11	Sell	F	5435	112608
0001380106-24-000084	4	2024-03-13	2024-03-11	Sell	F	7454	325403
0001380106-24-000082	4	2024-03-13	2024-03-11	Sell	F	10323	468824